Is Nabriva Therapeutics PLC - ADR (NBRV) Stock Worth a Buy Wednesday?

Wednesday, May 03, 2023 01:15 PM | InvestorsObserver Analysts

Mentioned in this article

Is Nabriva Therapeutics PLC - ADR (NBRV) Stock Worth a Buy Wednesday?

Nabriva Therapeutics PLC - ADR (NBRV) stock is lower by -79.35% over the last 12 months, and the average rating from Wall Street analysts is a Strong Sell. InvestorsObserver’s proprietary ranking system, gives NBRV stock a score of 19 out of a possible 100.

That rank is chiefly influenced by a short-term technical score of 1. NBRV's rank also includes a long-term technical score of 21.

NBRV has an Overall Score of 19. Find out what this means to you and get the rest of the rankings on NBRV!

See Full NBRV Report

What's Happening with NBRV Stock Today

Nabriva Therapeutics PLC - ADR (NBRV) stock is up 2.69% while the S&P 500 is higher by 0.29% as of 10:47 AM on Wednesday, May 3. NBRV is higher by $0.04 from the previous closing price of $1.54 on volume of 2,311 shares. Over the past year the S&P 500 has fallen -1.05% while NBRV is lower by -79.35%. NBRV lost -$21.32 per share in the over the last 12 months. Click Here to get the full Stock Report for Nabriva Therapeutics PLC - ADR stock.